6,8-Dibromoimidazo[1,5-a]pyridine

Catalog No.: 
ACWGNO581
CAS No.: 
1427398-85-3
Molecular Formula: 
C7H4Br2N2
Molecular Weight: 
275.93
6,8-Dibromoimidazo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%
250mg98%
1g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,8-Dibromoimidazo[1,5-a]pyridine
IUPAC Name6,8-dibromoimidazo[1,5-a]pyridine
MDL No.MFCD23711218
Molecular FormulaC7H4Br2N2
Molecular Weight275.93
SMILESBrC1=CC(Br)=CN2C1=CN=C2
InChI KeyYQNLRIJQBDQKGC-UHFFFAOYSA-N
Synonym6,8-dibromoimidazo[1,5-a]pyridine | 1427398-85-3 | SCHEMBL18379259 | MFCD23711218 | AKOS040768074 | SB73859 | BS-43239 | CS-0310410 | P19437
CAS No.1427398-85-3
PubChem CID124190123

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWGNO581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACWGNO581 route product structure diagram
    ACWGNO5811427398-85-3In Stock
Inquiry

2. ACWGNO581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWGNO581 route product structure diagram
    ACWGNO5811427398-85-3In Stock
Inquiry

3. ACWGNO581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWGNO581 route product structure diagram
    ACWGNO5811427398-85-3In Stock
Inquiry

Comments (0)